Home > Insider Trading > Filing (0001209191-15-026882)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Plc	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1342821	Jeff Himawan	21 Waterway Avenue, Suite 225 The Woodlands TX 77380		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-12	690,369	$4.31	690,369	No	4	X	Indirect	See Foot note
Common Stock	Disposition	2015-03-12	135,805	$4.04	554,564	No	4	D	Indirect	See Foot note
Common Stock	Disposition	2015-03-12	197,277	$22.59	357,287	No	4	S	Indirect	See Foot note
Common Stock	Disposition	2015-03-13	357,287	$22.35	0	No	4	S	Indirect	See Foot note

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See Foot note
No	4	D	Indirect	See Foot note
No	4	S	Indirect	See Foot note
No	4	S	Indirect	See Foot note

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Disposition	2015-03-12	690,369	$0.00	690,369	$4.31

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
690,369	2012-03-02	2017-03-02	No	4	X	Indirect

Footnotes

Represents shares underlying warrants. Essex Woodlands Health Ventures Fund, VII, L.P. (the "Fund") exercised warrants for 690,369 shares. Shares received by the Fund are net of shares withheld, as described in footnote (3), due to net exercise of warrants.
The securities are held directly by the Fund. The Reporting Person is a manager of Essex Woodlands Health Ventures VII, L.L.C., which is the general partner of Essex Woodlands Health Ventures VII, L.P., the general partner of the Fund. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
Represents 135,805 shares withheld in connection with the net exercise of warrants. Such shares are held by the issuer in satisfaction of the warrant's exercise price and did not involve any sale of shares by the Fund.
Price Range of $22.41 to $22.90.
Price Range of $22.20 to $22.62.